{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T22:47:44Z","timestamp":1780613264394,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T00:00:00Z","timestamp":1530921600000},"content-version":"am","delay-in-days":309,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402857"],"award-info":[{"award-number":["81402857"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81690264"],"award-info":[{"award-number":["81690264"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","award":["BMU20110263"],"award-info":[{"award-number":["BMU20110263"]}],"id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2015CB932100"],"award-info":[{"award-number":["2015CB932100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jconrel.2017.06.018","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T03:18:33Z","timestamp":1498533513000},"page":"174-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["The use of electronic-neutral penetrating peptides cyclosporin A to deliver pro-apoptotic peptide: A possibly better choice than positively charged TAT"],"prefix":"10.1016","volume":"261","author":[{"given":"Wei","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiucong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.06.018_bb0005","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1021\/nn4057269","article-title":"Cell-penetrating peptides: design, synthesis, and applications","volume":"8","author":"Copolovici","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2017.06.018_bb0010","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2013.11.020","article-title":"Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery","volume":"174","author":"Wang","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.06.018_bb0015","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.drudis.2012.03.002","article-title":"Cell-penetrating peptides: classes, origin, and current landscape","volume":"17","author":"Milletti","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2017.06.018_bb0020","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0092-8674(88)90263-2","article-title":"Cellular uptake of the tat protein from human immunodeficiency virus","volume":"55","author":"Frankel","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2017.06.018_bb0025","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1042\/BST0350784","article-title":"Arginine-rich peptides and their internalization mechanisms","volume":"35","author":"Futaki","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.jconrel.2017.06.018_bb0030","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jmr.630","article-title":"A brief introduction to cell-penetrating peptides","volume":"16","author":"Lundberg","year":"2003","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.jconrel.2017.06.018_bb0035","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1002\/cbic.200500044","article-title":"Break on through to the other side-biophysics and cell biology shed light on cell-penetrating peptides","volume":"6","author":"Fischer","year":"2005","journal-title":"ChemBioChem"},{"key":"10.1016\/j.jconrel.2017.06.018_bb0040","doi-asserted-by":"crossref","first-page":"14255","DOI":"10.1074\/jbc.270.24.14255","article-title":"Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence","volume":"270","author":"Lin","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2017.06.018_bb0045","doi-asserted-by":"crossref","first-page":"11819","DOI":"10.1073\/pnas.93.21.11819","article-title":"Identification of a functionally important sequence in the cytoplasmic tail of integrin beta 3 by using cell-permeable peptide analogs","volume":"93","author":"Liu","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2017.06.018_bb0050","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1016\/S0968-0896(02)00340-1","article-title":"A cell-penetrating peptide from a novel pVII-pIX phage-displayed random peptide library","volume":"10","author":"Gao","year":"2002","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jconrel.2017.06.018_bb0055","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1021\/cb100423u","article-title":"An unusual cell penetrating peptide identified using a plasmid display-based functional selection platform","volume":"6","author":"Gao","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jconrel.2017.06.018_bb0060","doi-asserted-by":"crossref","first-page":"25823","DOI":"10.1074\/jbc.M110.198267","article-title":"Fibroblast growth factor-12 (FGF12) translocation into intestinal epithelial cells is dependent on a novel cell-penetrating peptide domain: involvement of internalization in the in vivo role of exogenous FGF12","volume":"286","author":"Nakayama","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2017.06.018_bb0065","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.3390\/ph3123594","article-title":"Cell-penetrating penta-peptides (CPP5s): measurement of cell entry and protein-transduction activity","volume":"3","author":"Gomez","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jconrel.2017.06.018_bb0070","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1074\/jbc.M509813200","article-title":"Mechanism of uptake of C105Y, a novel cell-penetrating peptide","volume":"281","author":"Rhee","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2017.06.018_bb0075","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/j.biomaterials.2013.11.088","article-title":"Hydrophobic penetrating peptide PFVYLI-modified stealth liposomes for doxorubicin delivery in breast cancer therapy","volume":"35","author":"Cai","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.06.018_bb0080","article-title":"A nanomedicine based combination therapy based on QLPVM peptide functionalized liposomal tamoxifen and doxorubicin against luminal a breast cancer","author":"Wang","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.06.018_bb0085","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1166\/jbn.2016.2246","article-title":"The use of a hydrophobic binding peptide modified lipid nanocarrier improving tumor distribution and antitumor efficacy","volume":"12","author":"Gao","year":"2016","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.jconrel.2017.06.018_bb0090","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.addr.2007.10.008","article-title":"Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers","volume":"60","author":"Torchilin","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.06.018_bb0095","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/12469","article-title":"Anti-cancer activity of targeted pro-apoptotic peptides","volume":"5","author":"Ellerby","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2017.06.018_bb0100","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1158\/1535-7163.MCT-05-0509","article-title":"A mitochondrial targeted fusion peptide exhibits remarkable cytotoxicity","volume":"5","author":"Law","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2017.06.018_bb0105","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1166\/jbn.2016.2246","article-title":"The use ofa hydrophobic binding peptide modified lipid nanocarrier improving tumor distribution and antitumor efficacy","volume":"12","author":"Gao","year":"2016","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.jconrel.2017.06.018_bb0110","doi-asserted-by":"crossref","first-page":"15300","DOI":"10.1074\/jbc.M401604200","article-title":"Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors","volume":"280","author":"Richard","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2017.06.018_bb0115","doi-asserted-by":"crossref","unstructured":"E. Koren, V.P. Torchilin, Cell-penetrating peptides: breaking through to the other side, Trends Mol. Med., 18, 385\u2013393.","DOI":"10.1016\/j.molmed.2012.04.012"},{"key":"10.1016\/j.jconrel.2017.06.018_bb0120","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1021\/jm9509410","article-title":"De novo antimicrobial peptides with low mammalian cell toxicity","volume":"39","author":"Javadpour","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2017.06.018_bb0125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.etap.2014.11.013","article-title":"Macrophage apoptosis induced by aqueous C60 aggregates changing the mitochondrial membrane potential","volume":"39","author":"Zhang","year":"2015","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.06.018_bb0130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.yexmp.2015.06.013","article-title":"Quantum dot-based multispectral fluorescent imaging to quantitatively study co-expressions of Ki67 and HER2 in breast cancer","volume":"99","author":"Xiang","year":"2015","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.jconrel.2017.06.018_bb0135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1293\/tox.25.63","article-title":"Histopathology of incidental findings in cynomolgus monkeys (Macaca fascicularis) used in toxicity studies","volume":"25","author":"Sato","year":"2012","journal-title":"J. Toxicol. Pathol."},{"key":"10.1016\/j.jconrel.2017.06.018_bb0140","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.intimp.2009.03.015","article-title":"Gemcitabine directly inhibits myeloid derived suppressor cells in BALB\/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice","volume":"9","author":"Le","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2017.06.018_bb0145","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.tips.2010.11.005","article-title":"Biological responses towards cationic peptides and drug carriers","volume":"32","author":"Verdurmen","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2017.06.018_bb0150","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1039\/b904878b","article-title":"Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides","volume":"1","author":"Aguilera","year":"2009","journal-title":"Integr. Biol."},{"key":"10.1016\/j.jconrel.2017.06.018_bb0155","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/j.peptides.2011.09.017","article-title":"Blood pressure modulation following activation of mast cells by cationic cell penetrating peptides","volume":"32","author":"Basheer","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.jconrel.2017.06.018_bb0160","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1227\/NEU.0b013e31820c6cdc","article-title":"A review of laboratory and clinical data supporting the safety and efficacy of cyclosporin A in traumatic brain injury","volume":"68","author":"Lulic","year":"2011","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jconrel.2017.06.018_bb0165","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1034\/j.1399-0012.1999.130301.x","article-title":"Cyclosporine and tacrolimus (FK506): a comparison of efficacy and safety profiles","volume":"13","author":"Henry","year":"1999","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.jconrel.2017.06.018_bb0170","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1200\/JCO.1992.10.10.1624","article-title":"Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance","volume":"10","author":"Yahanda","year":"1992","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2017.06.018_bb0175","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1021\/bc025573a","article-title":"Characterization of novel histidine-tagged Tat-peptide complexes dual-labeled with (99m)Tc-tricarbonyl and fluorescein for scintigraphy and fluorescence microscopy","volume":"13","author":"Bullok","year":"2002","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2017.06.018_bb0180","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1021\/mp5008376","article-title":"Comparative biodistribution and pharmacokinetic analysis of cyclosporine-A in the brain upon intranasal or intravenous administration in an oil-in-water nanoemulsion formulation","volume":"12","author":"Yadav","year":"2015","journal-title":"Mol. Pharm."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917306818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917306818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:38:09Z","timestamp":1777509489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917306818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":36,"alternative-id":["S0168365917306818"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.06.018","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of electronic-neutral penetrating peptides cyclosporin A to deliver pro-apoptotic peptide: A possibly better choice than positively charged TAT","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}